Stock Radar: Time to buy? Granules India breaks out from 4-year corrective phase, says Ajit Mishra
“We have been seeing a steady uptrend in the pharma space and Granules is trading in sync with the move. Traders can buy the stock for a target of Rs 510 in the next 2-4 months,” Ajit Mishra, SVP - Technical Research, Religare Broking Ltd, said.